ANAPTYSBIO INC (ANAB) Stock Analyst Earnings Estimates
NASDAQ:ANAB - Nasdaq - US0327241065 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.29M -83.71% | 17.157M 66.73% | 91.28M 432.03% | 66.987M -26.61% | 83.324M 24.39% | 103.53M 24.25% | 111.9M 8.08% | 159.94M 42.93% | 298.42M 86.58% | 423.33M 41.86% | 568.82M 34.37% | |
| EBITDA YoY % growth | -114.47M -103.72% | -156.42M -36.65% | -114.343M 26.90% | -107.681M 5.83% | -104.514M 2.94% | -122.094M -16.82% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -115.15M -102.69% | -157.072M -36.41% | -114.949M 26.82% | -156.787M -36.40% | -154.409M 1.52% | -220.858M -43.03% | -271.846M -23.09% | -247.77M 8.86% | -85.924M 65.32% | 189.51M 320.55% | 381.09M 101.09% | |
| Operating Margin | -1,119.05% | -915.50% | -125.93% | -234.06% | -185.31% | -213.33% | -242.94% | -154.91% | -28.79% | 44.77% | 67.00% | |
| EPS YoY % growth | -4.57 -122.93% | -6.08 -33.04% | -5.21 14.31% | -5.41 -3.83% | -5.06 6.46% | -5.58 -10.23% | -6.57 -17.85% | -4.75 27.81% | -1.47 69.10% | 6.09 515.30% | 12.23 100.84% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.57 8.04% | -1.56 -36.84% | -1.24 -72.15% | -1.37 -6.98% | -1.49 5.10% | -1.53 2.21% | -1.64 -32.04% | -0.87 36.24% | -0.92 38.21% | -0.99 35.41% |
| Revenue Q2Q % growth | 11.783M 7.40% | 12.968M -56.80% | 15.363M -64.37% | 5.78M -79.19% | 10.2M -13.43% | 10.2M -21.34% | 10.2M -33.61% | 10.2M 76.47% | 10.2M | 10.2M |
| EBITDA Q2Q % growth | -36.689M 8.29% | -30.381M -36.26% | -13.938M -53.78% | -37.893M -38.33% | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -42.373M -5.09% | -42.321M -85.97% | -41.74M -331.65% | -44.015M -59.83% | -70.883M -67.28% | -74.426M -75.86% | -81.093M -94.28% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -1.28 21.95% | -1.28 | 0.00 | -0.12% |
| Q4 2024 Q2Q % growth | -0.72 54.72% | -1.65 | 0.93 | 56.40% |
| Q3 2024 Q2Q % growth | -1.14 19.15% | -1.68 | 0.54 | 32.14% |
| Q2 2024 Q2Q % growth | -1.71 -14.00% | -1.01 | -0.70 | -69.51% |
| Q1 2024 Q2Q % growth | -1.64 -3.80% | -1.60 | -0.04 | -2.69% |
| Q4 2023 Q2Q % growth | -1.59 -70.97% | -1.63 | 0.04 | 2.65% |
| Q3 2023 Q2Q % growth | -1.41 -19.49% | -1.83 | 0.42 | 22.95% |
| Q2 2023 Q2Q % growth | -1.50 -30.43% | -1.73 | 0.23 | 13.36% |
| Q1 2023 Q2Q % growth | -1.58 -20.61% | -1.07 | -0.51 | -47.81% |
| Q4 2022 Q2Q % growth | -0.93 17.70% | -0.98 | 0.05 | 4.74% |
| Q3 2022 Q2Q % growth | -1.18 -391.67% | -0.74 | -0.44 | -59.94% |
| Q2 2022 Q2Q % growth | -1.15 -5,650.00% | -1.04 | -0.11 | -10.35% |
| Q1 2022 Q2Q % growth | -1.31 -98.48% | -1.01 | -0.30 | -29.08% |
| Q4 2021 Q2Q % growth | -1.13 -194.17% | 2.62 | -3.75 | -143.06% |
| Q3 2021 Q2Q % growth | -0.24 72.41% | -0.93 | 0.69 | 74.10% |
| Q2 2021 Q2Q % growth | -0.02 97.47% | -0.11 | 0.09 | 81.70% |
| Q1 2021 Q2Q % growth | -0.66 -120.00% | -0.70 | 0.04 | 5.95% |
| Q4 2020 Q2Q % growth | 1.20 260.00% | 1.42 | -0.22 | -15.48% |
| Q3 2020 Q2Q % growth | -0.87 24.35% | -0.74 | -0.13 | -18.25% |
| Q2 2020 Q2Q % growth | -0.79 11.24% | -0.76 | -0.03 | -3.29% |
| Q1 2020 Q2Q % growth | -0.30 63.41% | -0.64 | 0.34 | 53.31% |
| Q4 2019 Q2Q % growth | -0.75 | -1.22 | 0.47 | 38.54% |
| Q3 2019 Q2Q % growth | -1.15 | -1.17 | 0.02 | 1.82% |
| Q2 2019 Q2Q % growth | -0.89 | -1.01 | 0.12 | 11.61% |
| Q1 2019 Q2Q % growth | -0.82 | -0.84 | 0.02 | 2.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 27.771M 286.84% | 15.579M | 12.192M | 78.26% |
| Q4 2024 Q2Q % growth | 43.113M 378.77% | 7.923M | 35.19M | 444.15% |
| Q3 2024 Q2Q % growth | 30.017M 804.67% | 7.01M | 23.007M | 328.20% |
| Q2 2024 Q2Q % growth | 10.971M 217.08% | 24.787M | -13.816M | -55.74% |
| Q1 2024 Q2Q % growth | 7.179M 422.49% | 4.047M | 3.132M | 77.39% |
| Q4 2023 Q2Q % growth | 9.005M 32.23% | 2.273M | 6.732M | 296.17% |
| Q3 2023 Q2Q % growth | 3.318M 157.21% | 2.481M | 837K | 33.74% |
| Q2 2023 Q2Q % growth | 3.46M 183.61% | 3.388M | 72K | 2.13% |
| Q1 2023 Q2Q % growth | 1.374M 41.65% | 3.647M | -2.273M | -62.33% |
| Q4 2022 Q2Q % growth | 6.81M 574.26% | 6.967M | -157K | -2.25% |
| Q3 2022 Q2Q % growth | 1.29M -93.82% | 10.55M | -9.26M | -87.77% |
| Q2 2022 Q2Q % growth | 1.22M -95.94% | 4.808M | -3.588M | -74.63% |
| Q1 2022 Q2Q % growth | 970K -91.38% | 5.155M | -4.185M | -81.18% |
| Q4 2021 Q2Q % growth | 1.01M -98.32% | 113.1M | -112.09M | -99.11% |
| Q3 2021 Q2Q % growth | 20.89M | 6.808M | 14.082M | 206.84% |
| Q2 2021 Q2Q % growth | 30.03M | 29.459M | 571K | 1.94% |
| Q1 2021 Q2Q % growth | 11.25M -25.00% | 9.577M | 1.673M | 17.47% |
| Q4 2020 Q2Q % growth | 60M 1,900.00% | 65.28M | -5.28M | -8.09% |
| Q3 2020 Q2Q % growth | 1.7M | -1.7M | -100.00% | |
| Q2 2020 Q2Q % growth | -100.00% | 2.368M | -2.368M | -100.00% |
| Q1 2020 Q2Q % growth | 15M | 6.375M | 8.625M | 135.29% |
| Q4 2019 Q2Q % growth | 3M | 2.04M | 960K | 47.06% |
| Q3 2019 Q2Q % growth | 3.173M | -3.173M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.68% | -8.57% | 0% | -2.28% |
| Revenue | 0% | 27.74% | 0% | 26.08% |